QIDX yields 0.93% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, QIDX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QIDX + JNJ for your $10,000?
QIDX targets US stocks of any capitalization with consistent history of earnings stability or growth, and strong prospects for continued earnings stability and growth based on research and analysis. The fund considers equity securities from four indices representing large-cap core, large-cap growth, mid-cap value, and small-cap value companies. Target allocations are set to 25% for each index. The advisor has discretion to adjust the funds sector exposure, investment style, or specific securities based on market conditions and other factors such as interest rates, trading volume and market sentiment, market trends and sectors, individual securities, and other financial data. Index reconstitution and rebalancing inform security selection. However, as an actively managed ETF, the fund manager has full discretion to buy or sell securities at any time.
Full QIDX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.